Los fármacos contra el colesterol producen diabetes

Medicina, psicología y salud pública

Moderador: Fisio

Los fármacos contra el colesterol producen diabetes

Notapor Fisio » Jue, 05 Sep 2013, 22:44

Los fármacos contra el colesterol producen diabetes. Los medicos callan. Los periodistas callan. Y luego que malo es el gobierno, y viva la sanidad pública. Ya, ya...

Objective To examine the risk of new onset diabetes among patients treated with different HMG-CoA reductase inhibitors (statins).

Design Population based cohort study with time to event analyses to estimate the relation between use of particular statins and incident diabetes. Hazard ratios were calculated to determine the effect of dose and type of statin on the risk of incident diabetes.

Setting Ontario, Canada.

Participants All patients aged 66 or older without diabetes who started treatment with statins from 1 August 1997 to 31 March 2010. The analysis was restricted to new users who had not been prescribed a statin in at least the preceding year. Patients with established diabetes before the start of treatment were excluded.

Interventions Treatment with statins.

Main outcome measure Incident diabetes.

Results Compared with pravastatin (the reference drug in all analyses), there was an increased risk of incident diabetes with atorvastatin (adjusted hazard ratio 1.22, 95% confidence interval 1.15 to 1.29), rosuvastatin (1.18, 1.10 to 1.26), and simvastatin (1.10, 1.04 to 1.17). There was no significantly increased risk among people who received fluvastatin (0.95, 0.81 to 1.11) or lovastatin (0.99, 0.86 to 1.14). The absolute risk for incident diabetes was about 31 and 34 events per 1000 person years for atorvastatin and rosuvastatin, respectively. There was a slightly lower absolute risk with simvastatin (26 outcomes per 1000 person years) compared with pravastatin (23 outcomes per 1000 person years). Our findings were consistent regardless of whether statins were used for primary or secondary prevention of cardiovascular disease. Although similar results were observed when statins were grouped by potency, the risk of incident diabetes associated with use of rosuvastatin became non-significant (adjusted hazard ratio 1.01, 0.94 to 1.09) when dose was taken into account.

Conclusions Compared with pravastatin, treatment with higher potency statins, especially atorvastatin and simvastatin, might be associated with an increased risk of new onset diabetes.

http://www.sciencedaily.com/releases/20 ... 223823.htm
Código de descuento Iherb JUY782

Dont believe bullshit
Avatar de Usuario
Administrador del Sitio
Mensajes: 3931
Registrado: Dom, 01 Sep 2013, 14:18

Volver a Ciencia y medicina

¿Quién está conectado?

Usuarios navegando por este Foro: Google [Bot] y 1 invitado